Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity

Publication date: Available online 24 June 2021Source: Cancer CellAuthor(s): Ariella B. Hanker, Benjamin P. Brown, Jens Meiler, Arnaldo Marín, Harikrishna S. Jayanthan, Dan Ye, Chang-Ching Lin, Hiroaki Akamatsu, Kyung-Min Lee, Sumanta Chatterjee, Dhivya R. Sudhan, Alberto Servetto, Monica Red Brewer, James P. Koch, Jonathan H. Sheehan, Jie He, Alshad S. Lalani, Carlos L. Arteaga
Source: Cancer Cell - Category: Cancer & Oncology Source Type: research